Viewing Study NCT06564194


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-25 @ 11:46 PM
Study NCT ID: NCT06564194
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-30
First Post: 2024-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
Sponsor: Immorna Biotherapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module